High efficiency and long-term intracellular activity of an enzymatic nanofactory based on metal-organic frameworks

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Lian, Xizhen ^a   Erazo Oliveras, Alfredo ^a   Pellois, Jean Philippe ^a   Zhou, Hong Cai ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; ENZYME; METAL ORGANIC FRAMEWORK; NANOPARTICLE; PROTEINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRYPSIN;

ANTIOXIDANT; CELLS AND CELL COMPONENTS; ENZYME; ENZYME ACTIVITY; OXYGEN; PH; REACTIVE OXYGEN SPECIES; TOXIC SUBSTANCE;

AQUEOUS SOLUTION; ARTICLE; CELL CULTURE; CELL ORGANELLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LYSOSOME; NUCLEAR PORE COMPLEX; PARTICLE SIZE; PH; PHOTON CORRELATION SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; WST ASSAY; X RAY POWDER DIFFRACTION; CHEMISTRY; CYTOPLASM; DRUG EFFECT; ENZYME ASSAY; HELA CELL LINE; METABOLISM; NANOTECHNOLOGY; OXIDATIVE STRESS; PROCEDURES;

CYTOPLASM; ENDOPEPTIDASES; ENZYME ASSAYS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; METAL-ORGANIC FRAMEWORKS; NANOTECHNOLOGY; ORGANELLES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85037838641     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-02103-0     Document Type: Article

References (80)

1. D'Astolfo, D. S. et al. Efficient intracellular delivery of native proteins. Cell 161, 674-690 (2015).
2. Desnick, R. J. & Schuchman, E. H. Enzyme replacement and enhancement therapies: Lessons from lysosomal disorders. Nat. Rev. Genet. 3, 954-966 (2002).
3. Freytag, S. O. et al. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose threedimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate-to high-risk prostate cancer. Cancer Res. 63, 7497-7506 (2003).
4. Lundberg, M. & Johansson, M. Is VP22 nuclear homing an artifact? Nat. Biotech. 19, 713-713 (2001).
5. Cavazzana-Calvo, M., Thrasher, A. & Mavilio, F. The future of gene therapy. Nature 427, 779-781 (2004).
6. Thomas, C. E., Ehrhardt, A. & Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346-358 (2003).
7. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419 (2003).
8. Otzen, D. Protein-surfactant interactions: a tale of many states. Biochim. Biophys. Acta 1814, 562-591 (2011).
9. Jevševar, S., Kunstelj, M. & Porekar, V. G. PEGylation of therapeutic proteins. Biotechnol. J. 5, 113-128 (2010).
10. Tanner, P., Onaca, O., Balasubramanian, V., Meier, W. & Palivan, C. G. Enzymatic cascade reactions inside polymeric nanocontainers: A means to combat oxidative stress. Chem. Eur. J. 17, 4552-4560 (2011).
11. Jadot, G., Vaille, A., Maldonado, J. & Vanelle, P. Clinical pharmacokinetics and delivery of bovine superoxide dismutase. Clin. Pharmacokinet. 28, 17-25 (1995).
12. Christian, D. A. et al. Polymersome carriers: From self-assembly to siRNA and protein therapeutics. Eur. J. Pharm. Biopharm. 71, 463-474 (2009).
13. Sercombe, L. et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015).
14. Immordino, M. L., Dosio, F. & Cattel, L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 1, 297-315 (2006).
15. Chen, Y.-P. et al. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: Superoxide dismutase. J. Am. Chem. Soc. 135, 1516-1523 (2013).
16. Discher, D. E. et al. Emerging applications of polymersomes in delivery: From molecular dynamics to shrinkage of tumors. Prog. Polym. Sci. 32, 838-857 (2007).
17. Schwendener, R. A. Liposomes as vaccine delivery systems: A review of the recent advances. Ther. Adv. Vaccine 2, 159-182 (2014).
18. Schwarze, S. R., Hruska, K. A. & Dowdy, S. F. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295 (2000).
19. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007).
20. Langer, R. & Tirrell, D. A. Designing materials for biology and medicine. Nature 428, 487-492 (2004).
21. Gref, R. et al. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603 (1994).
22. Fishburn, C. S. The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics. J. Pharm. Sci. 97, 4167-4183 (2008).
23. Pisal, D. S., Kosloski, M. P. & Balu-Iyer, S. V. Delivery of therapeutic proteins. J. Pharm. Sci. 99, 2557-2575 (2010).
24. Zhou, H.-C. & Kitagawa, S. Metal-organic frameworks (MOFs). Chem. Soc. Rev. 43, 5415-5418 (2014).
25. Horcajada, P. et al. Metal-organic frameworks in biomedicine. Chem. Rev. 112, 1232-1268 (2012).
26. Kreno, L. E. et al. Metal-organic framework materials as chemical sensors. Chem. Rev. 112, 1105-1125 (2012).
27. Sumida, K. et al. Carbon dioxide capture in metal-organic frameworks. Chem. Rev. 112, 724-781 (2012).
28. Zhou, H.-C., Long, J. R. & Yaghi, O. M. Introduction to metal-organic frameworks. Chem. Rev. 112, 673-674 (2012).
29. Lu, W. et al. Tuning the structure and function of metal-organic frameworks via linker design. Chem. Soc. Rev. 43, 5561-5593 (2014).
30. Murray, L. J., Dinca, M. & Long, J. R. Hydrogen storage in metal-organic frameworks. Chem. Soc. Rev. 38, 1294-1314 (2009).
31. Cao, Y. et al. Immobilization of bacillus subtilis lipase on a Cu-BTC based hierarchically porous metal-organic framework material: A biocatalyst for esterification. Dalton Trans. 45, 6998-7003 (2016).
32. Chen, Y. et al. How can proteins enter the interior of a MOF? Investigation of cytochrome c translocation into a MOF consisting of mesoporous cages with microporous windows. J. Am. Chem. Soc. 134, 13188-13191 (2012).
33. Lykourinou, V. et al. Immobilization of MP-11 into a mesoporous metalorganic framework, MP-11@mesoMOF: A new platform for enzymatic catalysis. J. Am. Chem. Soc. 133, 10382-10385 (2011).
34. Liu, W.-L. et al. Novel trypsin-FITC@MOF bioreactor efficiently catalyzes protein digestion. J. Mater. Chem. B 1, 928 (2013).
35. Lyu, F., Zhang, Y., Zare, R. N., Ge, J. & Liu, Z. One-pot synthesis of proteinembedded metal-organic frameworks with enhanced biological activities. Nano Lett. 14, 5761-5765 (2014).
36. Lian, X. et al. Enzyme-MOF (metal-organic framework) composites. Chem. Soc. Rev. 46, 3386-3401 (2017).
37. Cao, S.-L. et al. Novel nano-/micro-biocatalyst: Soybean epoxide hydrolase immobilized on UiO-66-NH2 MOF for efficient biosynthesis of enantiopure (R)-1, 2-octanediol in deep eutectic solvents. ACS Sustain. Chem. Engl. 4, 3586-3595 (2016).
38. Liang, K. et al. Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules. Nat. Commun. 6, 7240 (2015).
39. He, H. et al. Construction of thermophilic lipase-embedded metal-organic frameworks via biomimetic mineralization: a biocatalyst for ester hydrolysis and kinetic resolution. ACS Appl. Mater. Interfaces 8, 24517-24524 (2016).
40. Wu, X., Ge, J., Yang, C., Hou, M. & Liu, Z. Facile synthesis of multiple enzymecontaining metal-organic frameworks in a biomolecule-friendly environment. Chem. Commun. 51, 13408-13411 (2015).
41. Lian, X., Chen, Y.-P., Liu, T.-F. & Zhou, H.-C. Coupling two enzymes into a tandem nanoreactor utilizing a hierarchically structured MOF. Chem. Sci. 7, 6969-6973 (2016).
42. Kundu, T. et al. Mechanical downsizing of a gadolinium(III)-based metal-organic framework for anticancer drug delivery. Chem. Eur. J. 20, 10514-10518 (2014).
43. Hu, Q. et al. A low cytotoxic cationic metal-organic framework carrier for controllable drug release. J. Med. Chem. 57, 5679-5685 (2014).
44. Cooper, L. et al. A biocompatible porous Mg-gallate metal-organic framework as an antioxidant carrier. Chem. Commun. 51, 5848-5851 (2015).
45. Hidalgo, T. et al. Crystal structure dependent in vitro antioxidant activity of biocompatible calcium gallate MOFs. J. Mater. Chem. B 5, 2813-2822 (2017).
46. Gkaniatsou, E. et al. Metal-organic frameworks: A novel host platform for enzymatic catalysis and detection. Mater. Horiz. 4, 55-63 (2017).
47. Su, H. et al. A highly porous medical metal-organic framework constructed from bioactive curcumin. Chem. Commun. 51, 5774-5777 (2015).
48. Zhu, X. et al. Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release. Chem. Commun. 50, 8779-8782 (2014).
49. Baati, T. et al. In depth analysis of the in vivo toxicity of nanoparticles of porous iron(III) metal-organic frameworks. Chem. Sci. 4, 1597-1607 (2013).
50. Vasconcelos, I. B. et al. Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8. RSC Adv. 2, 9437-9442 (2012).
51. Ruyra, À. et al. Synthesis, culture medium stability, and in vitro and in vivo zebrafish embryo toxicity of metal-organic framework nanoparticles. Chem. Eur. J. 21, 2508-2518 (2015).
52. Lucena, F. R. S. et al. Induction of cancer cell death by apoptosis and slow release of 5-fluoracil from metal-organic frameworks Cu-BTC. Biomed. Pharmacother. 67, 707-713 (2013).
53. Feng, D. et al. Stable metal-organic frameworks containing single-molecule traps for enzyme encapsulation. Nat. Commun. 6, 5979 (2015).
54. Schieber, M. & Chandel, N. S. ROS function in redox signaling and oxidative stress. Curr. Biol. 24, R453-R462 (2014).
55. Uttara, B., Singh, A. V., Zamboni, P. & Mahajan, R. T. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7, 65-74 (2009).
56. Pisoschi, A. M. & Pop, A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur. J. Med. Chem. 97, 55-74 (2015).
57. Adly, A. A. Oxidative stress and disease: an updated review. Res. J. Immunol. 3, 129-145 (2010).
58. Luzio, J. P., Pryor, P. R. & Bright, N. A. Lysosomes: Fusion and function. Nat. Rev. Mol. Cell Biol. 8, 622-632 (2007).
59. Hough, M. A. & Hasnain, S. S. Crystallographic structures of bovine copperzinc superoxide dismutase reveal asymmetry in two subunits: Functionally important three and five coordinate copper sites captured in the same crystal. J. Mol. Biol. 287, 579-592 (1999).
60. Yonekura, K. & Maki-Yonekura, S. Refinement of cryo-EM structures using scattering factors of charged atoms. J. Appl. Crystallogr. 49, 1517-1523 (2016).
61. Schrader, M. & Fahimi, H. D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta 1763, 1755-1766 (2006).
62. Fukai, T. & Ushio-Fukai, M. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. Antioxid. Redox. Signal. 15, 1583-1606 (2011).
63. Erazo-Oliveras, A. et al. The late endosome and its lipid BMP act as gateways for efficient cytosolic access of the delivery agent dfTAT and its macromolecular cargos. Cell Chem. Biol. 23, 598-607 (2016).
64. Erazo-Oliveras, A. et al. Protein delivery into live cells by incubation with an endosomolytic agent. Nat. Methods 11, 861-867 (2014).
65. Najjar, K., Erazo-Oliveras, A., Brock, D. J., Wang, T.-Y. & Pellois, J.-P. An L-to D-amino acid conversion in the cell penetrating peptide dfTAT influences proteolytic stability, endocytic uptake, and endosomal escape. J. Biol. Chem. 292, 847-861 (2016).
66. Schmölzer, P. M., Höftberger, M. & Foissner, I. Plasma membrane domains participate in pH banding of Chara internodal cells. Plant Cell Physiol. 52, 1274-1288 (2011).
67. Raghu, K. et al. Paraquat poisoning: A case report and review of literature. J. Fam. Commun. Med. 20, 198-200 (2013).
68. Benov, L. How superoxide radical damages the cell. Protoplasma 217, 33-36 (2001).
69. Keyer, K., Gort, A. S. & Imlay, J. A. Superoxide and the production of oxidative DNA damage. J. Bacteriol. 177, 6782-6790 (1995).
70. Oakley, F. D., Abbott, D., Li, Q. & Engelhardt, J. F. Signaling components of redox active endosomes: The redoxosomes. Antioxid. Redox. Signal. 11, 1313-1333 (2008).
71. Singhal, A., Morris, V. B., Labhasetwar, V. & Ghorpade, A. Nanoparticlemediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 4, e903 (2013).
72. Maina, J. W. et al. Capsosomes as long-term delivery vehicles for protein therapeutics. Langmuir 31, 7776-7781 (2015).
73. Chu, B. Y., Kobiasi, M. A., Zeng, W., Mainwaring, D. & Jackson, D. C. Chitosan-based particles as biocompatible delivery vehicles for peptide and protein-based vaccines. Procedia Vaccinol. 6, 74-79 (2012).
74. Tanner, P. et al. Can polymeric vesicles that confine enzymatic reactions act as simplified organelles? FEBS Lett. 585, 1699-1706 (2011).
75. Tanner, P. et al. Polymeric vesicles: From drug carriers to nanoreactors and artificial organelles. Acc. Chem. Res. 44, 1039-1049 (2011).
76. Tanner, P., Balasubramanian, V. & Palivan, C. G. Aiding nature's organelles: artificial peroxisomes play their role. Nano Lett. 13, 2875-2883 (2013).
77. Garni, M. et al. Artificial organelles: Reactions inside protein-polymer supramolecular assemblies. Chimia 70, 424-427 (2016).
78. Liu, J. et al. DNA-mediated self-organization of polymeric nanocompartments leads to interconnected artificial organelles. Nano Lett. 16, 7128-7136 (2016).
79. Schindelin, J., Rueden, C. T., Hiner, M. C. & Eliceiri, K. W. The ImageJ ecosystem: an open platform for biomedical image analysis. Mol. Reprod. Dev. 82, 518-529 (2015).
80. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012).